Using patient-centered end-points in older adults participating in clinical trials


Submitted: 21 March 2016
Accepted: 6 April 2016
Published: 14 April 2016
Abstract Views: 1306
PDF: 683
HTML: 189
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Conventional end-points, primarily based on the pharmacodynamic effects of a specific drug, are used to assess the efficacy of pharmacological treatment in clinical trials. However, their application and interpretation in complex frail older patients, a patient group with high inter-individual variability, multiple coexisting disease states and prescribed medications, is becoming increasingly questionable. National surveys and qualitative studies have convincingly shown that the maintenance of functional independence is key to self-rated health and well being in old age. Therefore, the use of unconventional, patientcentered, end-points focused on functional status and perceived health seems appropriate, in combination with conventional end-points, to comprehensively investigate the impact of pharmacological treatments in this patient group. The recent availability of objective, quantifiable, and robust scoring tools, such as the multidimensional prognostic index, to assess key functional domains and clinical outcomes offers a unique opportunity to adequately characterize patient-centered endpoints in future clinical trials in older patients.

Mangoni, A. A., & Ruxton, K. (2016). Using patient-centered end-points in older adults participating in clinical trials. Geriatric Care, 2(1). https://doi.org/10.4081/gc.2016.5893

Downloads

Download data is not yet available.

Citations